Citation Impact
Citing Papers
Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]
2011
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
2015 StandoutNobel
Capsaicin (TRPV1 Agonist) Therapy for Pain Relief
2008
Predictors of opioid misuse in patients with chronic pain: a prospective cohort study
2006
Assessment of pain
2008 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evidence-Based Review
2007
Efficacy of Opioids for Chronic Pain
2008
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings
2006
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
2011 Standout
Bowel Disorders
2016 Standout
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
2006
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study
2007
Advances in the management of diabetic peripheral neuropathy
2009
Oxycodone for neuropathic pain and fibromyalgia in adults
2014
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
The Pain Quality Assessment Scale: Assessment of Pain Quality in Carpal Tunnel Syndrome
2006
Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin
2005
Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain
2010
Controlled‐Release Oxycodone and Naloxone in the Treatment of Chronic Low Back Pain: A Placebo‐Controlled, Randomized Study
2013
A new definition of neuropathic pain
2011 Standout
Non-specific low back pain
2016 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome
2007 Standout
Validation of a Modified Version of the Brief Pain Inventory for Painful Diabetic Peripheral Neuropathy
2005
Assessment of Pain Quality in a Clinical Trial of Gabapentin Extended Release for Postherpetic Neuralgia
2009
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Prevalence of Chronic Pain in a Representative Sample in the United States
2008
Therapie chronischer Schmerzen mit oralem retardiertem Oxycodon
2005
Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evaluation of Functional Outcomes
2007
Trends in long‐term opioid therapy for chronic non‐cancer pain
2009
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord
2008 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Opioide bei chronischem neuropathischem Schmerz
2014
Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
2005
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Oxycodone Controlled-Release as??First-Choice Therapy for Moderate-to-Severe Cancer Pain in??Italian Patients
2008
EFNS guidelines on pharmacological treatment of neuropathic pain
2006
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Peripheral axonal injury results in reduced μ opioid receptor pre- and post-synaptic action in the spinal cord☆
2005
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
Oral or transdermal opioids for osteoarthritis of the knee or hip
2009
EFNS guidelines on neuropathic pain assessment: revised 2009
2010
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy
2006
Neuropathic pain in the general population: A systematic review of epidemiological studies
2013 Standout
Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials
2007
Diabetic neuropathy: clinical manifestations and current treatments
2012
Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings From a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline
2009
Microneedle pretreatment improves efficacy of cutaneous topical anesthesia
2010
Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase
2010
Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis
2012
A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain
2011
Prolonged‐release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients
2008
The use of complementary and alternative medicines by patients with peripheral neuropathy
2003
Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain
2006
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Opioid-induced bowel dysfunction in cancer-related pain: Causes, consequences, and a novel approach for its management
2018
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
2015
Tramadol for neuropathic pain
2006
Evidence‐based guideline: Treatment of painful diabetic neuropathy—report of the american association of neuromuscular and electrodiagnostic medicine, the american academy of neurology, and the american academy of physical medicine & rehabilitation
2011
Defining clinical issues around tolerance, hyperalgesia, and addiction: A quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice
2011
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Microneedles for drug and vaccine delivery
2012 Standout
The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
2010
Critical review of oral drug treatments for diabetic neuropathic pain—clinical outcomes based on efficacy and safety data from placebo‐controlled and direct comparative studies
2005
Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain
2009
Diabetic neuropathy
2019
Osteoarthritis
2019 Standout
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
2009
Algorithm for neuropathic pain treatment: An evidence based proposal
2005
The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain
2014
Painful Diabetic Polyneuropathy
2011
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
2004
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
2004
Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
2016
Lacosamide in Painful Diabetic Peripheral Neuropathy
2007
Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy
2008
Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic Pain
2006
Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain
2006
Diabetic Neuropathies
2005 Standout
Comprehensive Foot Examination and Risk Assessment
2008 Standout
Neuropathic Pain
2009
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Opioids in the Management of ChronicNon-Cancer Pain: An Update of AmericanSociety of the Interventional Pain Physicians’(ASIPP) Guidelines
2008
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
2016 Standout
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
2010
New perspectives on the management of diabetic peripheral neuropathic pain
2006
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
Assessment of Neuropathic Pain
2010
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Cannabinoids for Medical Use
2015 Standout
Diabetic Somatic Neuropathies
2004 Standout
Long-term opioid management for chronic noncancer pain
2010
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Pharmacologic Interventions for Painful Diabetic Neuropathy
2014
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Opioid Complications and Side Effects
2008 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Opioid Guidelines in the Management ofChronic Non-Cancer Pain
2006
Opioids for neuropathic pain
2013
Oral or transdermal opioids for osteoarthritis of the knee or hip
2014
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of P. Richards being referenced
The Validity of the Neuropathic Pain Scale for Assessing Diabetic Neuropathic Pain in a Clinical Trial
2005
A Novel Needle-Free Powder Lidocaine Delivery System for Rapid Local Analgesia
2007
Treatment of Persistent Pain Associated With Osteoarthritis With Controlled-Release Oxycodone Tablets in a Randomized Controlled Clinical Trial
2005
A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain
2011
Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry Study
2007
(781)
2007
(760)
2006
(312/759)
2006
Controlled-release oxycodone for pain in diabetic neuropathy
2003